The global patent landscape of HER2-targeted biologics - Nature Biotechnology

Indonesia Berita Berita

The global patent landscape of HER2-targeted biologics - Nature Biotechnology
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 63%

The global patent landscape of HER2-targeted biologics

This study was supported by the National Science and Technology Major project , the National Natural Science Foundation of China project , the Sun Yat-sen University Clinical Research 5010 Program , the Guangzhou Science and Technology Major Program , the Guangzhou Science and Technology Program , the Medical Artificial Intelligence Project of Sun Yat-sen Memorial Hospital , the CSCO-Hengrui Cancer Research Foundation , the Guangdong Basic and Applied Basic Research Foundation project , the...

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Oncology, Breast Tumor Centre, Phase I Clinical Trial Centre, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, ChinaDepartment of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Taipa,...

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

NatureBiotech /  🏆 231. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Nature Biotechnology - Expansion microscopyNature Biotechnology - Expansion microscopyThe June issue is live Our cover features an expansion microscopy technique developed by Klimas et al. that retains nucleic acids, proteins and lipids without the need for a separate anchoring step
Baca lebih lajut »

Why gene therapies must go virus-free - Nature BiotechnologyWhy gene therapies must go virus-free - Nature BiotechnologyGene therapies have made spectacular progress in delivering new cures for previously intractable disease, but they remain the world’s most expensive treatments. Now companies are replacing the virus in gene therapies with new delivery technologies that promise not only to overcome the limitations of viral vectors but to slash production costs too.
Baca lebih lajut »

A call for an ‘Asilomar’ for cultivated meat and seafood - Nature BiotechnologyA call for an ‘Asilomar’ for cultivated meat and seafood - Nature BiotechnologyNature Biotechnology - A call for an ‘Asilomar’ for cultivated meat and seafood
Baca lebih lajut »

Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos - Nature BiotechnologyAdenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos - Nature BiotechnologyAdenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos
Baca lebih lajut »

Inference and reconstruction of the heimdallarchaeial ancestry of eukaryotes - NatureInference and reconstruction of the heimdallarchaeial ancestry of eukaryotes - NatureAnalyses of multiple phylogenetic marker datasets of Asgard archaea provide insight into the transition from prokaryotes to eukaryotes, specifically placing eukaryotes within Asgard archaea and as a sister lineage to Hodarchaeales.
Baca lebih lajut »

CeCe Peniston Chalks Anita Baker & Babyface Feud To Nature Of Show BusinessCeCe Peniston Chalks Anita Baker & Babyface Feud To Nature Of Show BusinessAnita Baker's decision to erase Babyface from her tour doesn't surprise R&B singer CeCe Peniston all that much ... she calls it showbiz!!!
Baca lebih lajut »



Render Time: 2025-02-27 22:58:15